Abbisko Therapeutics discovers and develops small‑molecule precision‑oncology and immuno‑oncology drugs that target validated oncogenic drivers and immune pathways, such as CSF‑1R, FGFR4, KRAS G12D, EGFR C797S, PD‑L1 and CXCR4. Leveraging an in‑house multi‑dimensional R&D platform that integrates cancer genomics, medicinal chemistry and biomarker science, the company advances a pipeline of over ten oral candidates, with several in clinical stages, through monotherapy and combination trials for solid tumors and rare diseases in China and globally.

AgiBot develops and manufactures humanoid robots and embodied intelligence systems designed for various applications, including interactive services and flexible manufacturing. Their technology enhances productivity by automating tasks in diverse environments, addressing labor shortages and operational inefficiencies.

Green Li-ion develops a modular hardware solution that utilizes GREEN HYDROREJUVENATION™ technology to convert spent lithium-ion batteries into precursor cathode active material, graphite, and technical-grade lithium carbonate. This process addresses the environmental impact of electronic waste by efficiently reclaiming valuable battery materials for reuse in manufacturing.

Provides AI-powered chatbots and workflow automation tools tailored for businesses using WhatsApp as their primary communication platform. Eliminates missed sales opportunities, inefficient spreadsheet-based operations, and high development costs by deploying no-code and low-code solutions that are 10x faster and cheaper than traditional methods.

Pedro is a microfinance platform that offers unsecured loans with a flexible interest rate model that decreases as borrowers make timely payments. The service enhances financial inclusion by providing accessible credit options, enabling users to improve their cash flow and overall quality of life.

This startup offers an online platform that empowers women and LGBTQ artists to launch and manage NFT initiatives, utilizing decentralized finance tools to enhance visibility and access to resources. By fostering a community-driven ecosystem, the platform addresses the lack of equitable opportunities in the crypto space for underrepresented creators.

Westlake Omics develops AI-powered proteomics technology that enhances the precision of tumor diagnostics through quantitative and spatial proteomics methods. By providing reliable diagnostic tools, the company aims to improve patient outcomes in clinical settings by enabling accurate tumor characterization.

MAYCUR.COM offers cloud-based financial products that utilize advanced data analytics and machine learning to enhance financial decision-making for businesses. The platform addresses inefficiencies in financial management by providing real-time insights and automated reporting, enabling companies to optimize their financial operations.

XinpleTek develops high-performance RF front-end solutions for mobile communication and IoT devices, utilizing advanced RF component technology to enhance wireless connectivity. Their products address the need for efficient and reliable signal transmission in the rapidly growing 5G and IoT markets.

The startup develops TCR gene therapy solutions that provide personalized immunotherapy for cancer patients by engineering T-cell receptors to target specific tumor antigens. This approach enhances treatment efficacy and minimizes side effects compared to traditional therapies.